The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Psilocybin Assisted Therapy-Global Market Insights and Sales Trends 2024
Synopsis
The global Psilocybin Assisted Therapy market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Psilocybin Assisted Therapy in various end use industries. The expanding demands from the Cluster Headaches, Anxiety Disorders and Psychiatric Disorders,, are propelling Psilocybin Assisted Therapy market. Natural, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Synthetic segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Psilocybin Assisted Therapy, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Psilocybin Assisted Therapy market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Psilocybin Assisted Therapy market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Psilocybin Assisted Therapy sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Psilocybin Assisted Therapy covered in this report include MindMed, Compass Pathways, ATAI Life Sciences, Field Trip, DemeRx, Eleusis, Hikma Pharmaceuticals PLC, Pfizer and Verrian, etc.
The global Psilocybin Assisted Therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
MindMed
Compass Pathways
ATAI Life Sciences
Field Trip
DemeRx
Eleusis
Hikma Pharmaceuticals PLC
Pfizer
Verrian
Jazz Pharmaceuticals
Global Psilocybin Assisted Therapy market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Psilocybin Assisted Therapy market, Segment by Type:
Natural
Synthetic
Global Psilocybin Assisted Therapy market, by Application
Cluster Headaches
Anxiety Disorders
Psychiatric Disorders
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Psilocybin Assisted Therapy manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Psilocybin Assisted Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global Psilocybin Assisted Therapy market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Psilocybin Assisted Therapy in various end use industries. The expanding demands from the Cluster Headaches, Anxiety Disorders and Psychiatric Disorders,, are propelling Psilocybin Assisted Therapy market. Natural, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Synthetic segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Psilocybin Assisted Therapy, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Psilocybin Assisted Therapy market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Psilocybin Assisted Therapy market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Psilocybin Assisted Therapy sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Psilocybin Assisted Therapy covered in this report include MindMed, Compass Pathways, ATAI Life Sciences, Field Trip, DemeRx, Eleusis, Hikma Pharmaceuticals PLC, Pfizer and Verrian, etc.
The global Psilocybin Assisted Therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
MindMed
Compass Pathways
ATAI Life Sciences
Field Trip
DemeRx
Eleusis
Hikma Pharmaceuticals PLC
Pfizer
Verrian
Jazz Pharmaceuticals
Global Psilocybin Assisted Therapy market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Psilocybin Assisted Therapy market, Segment by Type:
Natural
Synthetic
Global Psilocybin Assisted Therapy market, by Application
Cluster Headaches
Anxiety Disorders
Psychiatric Disorders
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Psilocybin Assisted Therapy manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Psilocybin Assisted Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Psilocybin Assisted Therapy Market Overview
1.1 Psilocybin Assisted Therapy Product Overview
1.2 Psilocybin Assisted Therapy Market Segment by Type
1.2.1 Natural
1.2.2 Synthetic
1.3 Global Psilocybin Assisted Therapy Market Size by Type
1.3.1 Global Psilocybin Assisted Therapy Market Size Overview by Type (2018-2029)
1.3.2 Global Psilocybin Assisted Therapy Historic Market Size Review by Type (2018-2023)
1.3.3 Global Psilocybin Assisted Therapy Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Psilocybin Assisted Therapy Sales Breakdown by Type (2018-2023)
1.4.2 Europe Psilocybin Assisted Therapy Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Psilocybin Assisted Therapy Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Psilocybin Assisted Therapy Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Psilocybin Assisted Therapy Sales Breakdown by Type (2018-2023)
2 Global Psilocybin Assisted Therapy Market Competition by Company
2.1 Global Top Players by Psilocybin Assisted Therapy Sales (2018-2023)
2.2 Global Top Players by Psilocybin Assisted Therapy Revenue (2018-2023)
2.3 Global Top Players by Psilocybin Assisted Therapy Price (2018-2023)
2.4 Global Top Manufacturers Psilocybin Assisted Therapy Manufacturing Base Distribution, Sales Area, Product Type
2.5 Psilocybin Assisted Therapy Market Competitive Situation and Trends
2.5.1 Psilocybin Assisted Therapy Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Psilocybin Assisted Therapy Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Psilocybin Assisted Therapy as of 2022)
2.7 Date of Key Manufacturers Enter into Psilocybin Assisted Therapy Market
2.8 Key Manufacturers Psilocybin Assisted Therapy Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Psilocybin Assisted Therapy Status and Outlook by Region
3.1 Global Psilocybin Assisted Therapy Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Psilocybin Assisted Therapy Historic Market Size by Region
3.2.1 Global Psilocybin Assisted Therapy Sales in Volume by Region (2018-2023)
3.2.2 Global Psilocybin Assisted Therapy Sales in Value by Region (2018-2023)
3.2.3 Global Psilocybin Assisted Therapy Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Psilocybin Assisted Therapy Forecasted Market Size by Region
3.3.1 Global Psilocybin Assisted Therapy Sales in Volume by Region (2024-2029)
3.3.2 Global Psilocybin Assisted Therapy Sales in Value by Region (2024-2029)
3.3.3 Global Psilocybin Assisted Therapy Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Psilocybin Assisted Therapy by Application
4.1 Psilocybin Assisted Therapy Market Segment by Application
4.1.1 Cluster Headaches
4.1.2 Anxiety Disorders
4.1.3 Psychiatric Disorders
4.2 Global Psilocybin Assisted Therapy Market Size by Application
4.2.1 Global Psilocybin Assisted Therapy Market Size Overview by Application (2018-2029)
4.2.2 Global Psilocybin Assisted Therapy Historic Market Size Review by Application (2018-2023)
4.2.3 Global Psilocybin Assisted Therapy Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Psilocybin Assisted Therapy Sales Breakdown by Application (2018-2023)
4.3.2 Europe Psilocybin Assisted Therapy Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Psilocybin Assisted Therapy Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Psilocybin Assisted Therapy Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Psilocybin Assisted Therapy Sales Breakdown by Application (2018-2023)
5 North America Psilocybin Assisted Therapy by Country
5.1 North America Psilocybin Assisted Therapy Historic Market Size by Country
5.1.1 North America Psilocybin Assisted Therapy Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Psilocybin Assisted Therapy Sales in Volume by Country (2018-2023)
5.1.3 North America Psilocybin Assisted Therapy Sales in Value by Country (2018-2023)
5.2 North America Psilocybin Assisted Therapy Forecasted Market Size by Country
5.2.1 North America Psilocybin Assisted Therapy Sales in Volume by Country (2024-2029)
5.2.2 North America Psilocybin Assisted Therapy Sales in Value by Country (2024-2029)
6 Europe Psilocybin Assisted Therapy by Country
6.1 Europe Psilocybin Assisted Therapy Historic Market Size by Country
6.1.1 Europe Psilocybin Assisted Therapy Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Psilocybin Assisted Therapy Sales in Volume by Country (2018-2023)
6.1.3 Europe Psilocybin Assisted Therapy Sales in Value by Country (2018-2023)
6.2 Europe Psilocybin Assisted Therapy Forecasted Market Size by Country
6.2.1 Europe Psilocybin Assisted Therapy Sales in Volume by Country (2024-2029)
6.2.2 Europe Psilocybin Assisted Therapy Sales in Value by Country (2024-2029)
7 Asia-Pacific Psilocybin Assisted Therapy by Region
7.1 Asia-Pacific Psilocybin Assisted Therapy Historic Market Size by Region
7.1.1 Asia-Pacific Psilocybin Assisted Therapy Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Psilocybin Assisted Therapy Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Psilocybin Assisted Therapy Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Psilocybin Assisted Therapy Forecasted Market Size by Region
7.2.1 Asia-Pacific Psilocybin Assisted Therapy Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Psilocybin Assisted Therapy Sales in Value by Region (2024-2029)
8 Latin America Psilocybin Assisted Therapy by Country
8.1 Latin America Psilocybin Assisted Therapy Historic Market Size by Country
8.1.1 Latin America Psilocybin Assisted Therapy Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Psilocybin Assisted Therapy Sales in Volume by Country (2018-2023)
8.1.3 Latin America Psilocybin Assisted Therapy Sales in Value by Country (2018-2023)
8.2 Latin America Psilocybin Assisted Therapy Forecasted Market Size by Country
8.2.1 Latin America Psilocybin Assisted Therapy Sales in Volume by Country (2024-2029)
8.2.2 Latin America Psilocybin Assisted Therapy Sales in Value by Country (2024-2029)
9 Middle East and Africa Psilocybin Assisted Therapy by Country
9.1 Middle East and Africa Psilocybin Assisted Therapy Historic Market Size by Country
9.1.1 Middle East and Africa Psilocybin Assisted Therapy Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Psilocybin Assisted Therapy Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Psilocybin Assisted Therapy Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Psilocybin Assisted Therapy Forecasted Market Size by Country
9.2.1 Middle East and Africa Psilocybin Assisted Therapy Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Psilocybin Assisted Therapy Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 MindMed
10.1.1 MindMed Company Information
10.1.2 MindMed Introduction and Business Overview
10.1.3 MindMed Psilocybin Assisted Therapy Sales, Revenue and Gross Margin (2018-2023)
10.1.4 MindMed Psilocybin Assisted Therapy Products Offered
10.1.5 MindMed Recent Development
10.2 Compass Pathways
10.2.1 Compass Pathways Company Information
10.2.2 Compass Pathways Introduction and Business Overview
10.2.3 Compass Pathways Psilocybin Assisted Therapy Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Compass Pathways Psilocybin Assisted Therapy Products Offered
10.2.5 Compass Pathways Recent Development
10.3 ATAI Life Sciences
10.3.1 ATAI Life Sciences Company Information
10.3.2 ATAI Life Sciences Introduction and Business Overview
10.3.3 ATAI Life Sciences Psilocybin Assisted Therapy Sales, Revenue and Gross Margin (2018-2023)
10.3.4 ATAI Life Sciences Psilocybin Assisted Therapy Products Offered
10.3.5 ATAI Life Sciences Recent Development
10.4 Field Trip
10.4.1 Field Trip Company Information
10.4.2 Field Trip Introduction and Business Overview
10.4.3 Field Trip Psilocybin Assisted Therapy Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Field Trip Psilocybin Assisted Therapy Products Offered
10.4.5 Field Trip Recent Development
10.5 DemeRx
10.5.1 DemeRx Company Information
10.5.2 DemeRx Introduction and Business Overview
10.5.3 DemeRx Psilocybin Assisted Therapy Sales, Revenue and Gross Margin (2018-2023)
10.5.4 DemeRx Psilocybin Assisted Therapy Products Offered
10.5.5 DemeRx Recent Development
10.6 Eleusis
10.6.1 Eleusis Company Information
10.6.2 Eleusis Introduction and Business Overview
10.6.3 Eleusis Psilocybin Assisted Therapy Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Eleusis Psilocybin Assisted Therapy Products Offered
10.6.5 Eleusis Recent Development
10.7 Hikma Pharmaceuticals PLC
10.7.1 Hikma Pharmaceuticals PLC Company Information
10.7.2 Hikma Pharmaceuticals PLC Introduction and Business Overview
10.7.3 Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Products Offered
10.7.5 Hikma Pharmaceuticals PLC Recent Development
10.8 Pfizer
10.8.1 Pfizer Company Information
10.8.2 Pfizer Introduction and Business Overview
10.8.3 Pfizer Psilocybin Assisted Therapy Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Pfizer Psilocybin Assisted Therapy Products Offered
10.8.5 Pfizer Recent Development
10.9 Verrian
10.9.1 Verrian Company Information
10.9.2 Verrian Introduction and Business Overview
10.9.3 Verrian Psilocybin Assisted Therapy Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Verrian Psilocybin Assisted Therapy Products Offered
10.9.5 Verrian Recent Development
10.10 Jazz Pharmaceuticals
10.10.1 Jazz Pharmaceuticals Company Information
10.10.2 Jazz Pharmaceuticals Introduction and Business Overview
10.10.3 Jazz Pharmaceuticals Psilocybin Assisted Therapy Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Jazz Pharmaceuticals Psilocybin Assisted Therapy Products Offered
10.10.5 Jazz Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Psilocybin Assisted Therapy Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Psilocybin Assisted Therapy Industrial Chain Analysis
11.4 Psilocybin Assisted Therapy Market Dynamics
11.4.1 Psilocybin Assisted Therapy Industry Trends
11.4.2 Psilocybin Assisted Therapy Market Drivers
11.4.3 Psilocybin Assisted Therapy Market Challenges
11.4.4 Psilocybin Assisted Therapy Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Psilocybin Assisted Therapy Distributors
12.3 Psilocybin Assisted Therapy Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
